Stocks in the News This Week Under 5¢: $HALB
https://topnewsguide.com/2022/10/14/stocks-in...alst-mmmw/
Although the markets are not particularly steady at the moment there are still certain stocks in the penny stocks space that may be worth looking into for investors. However, at the same time, it ought to be noted that investors need to be a bit more selective and narrow down the category of stocks they choose to look into. This article is going to give you a quick look into some stocks trading below 5 cents which may be worth tracking at this point in time.
Halberd Corporation (OTCMKTS: HALB) – The next one to look into in this category is the Halberd Corporation stock. The company was in the news earlier on in the week after it announced that it had been successful in demonstrating that it could remove Interleukin-6 from human blood serum. It was demonstrated during the course of in-vitro laboratory studies.
It should be noted that an excess of Interleukin-6 is known to cause a range of health adversities in individuals. Halberd has managed to make many such findings throughout this year and it may be a good idea for investors to keep an eye on it.
https://topnewsguide.com/2022/10/14/stocks-in...alst-mmmw/
Although the markets are not particularly steady at the moment there are still certain stocks in the penny stocks space that may be worth looking into for investors. However, at the same time, it ought to be noted that investors need to be a bit more selective and narrow down the category of stocks they choose to look into. This article is going to give you a quick look into some stocks trading below 5 cents which may be worth tracking at this point in time.
Halberd Corporation (OTCMKTS: HALB) – The next one to look into in this category is the Halberd Corporation stock. The company was in the news earlier on in the week after it announced that it had been successful in demonstrating that it could remove Interleukin-6 from human blood serum. It was demonstrated during the course of in-vitro laboratory studies.
It should be noted that an excess of Interleukin-6 is known to cause a range of health adversities in individuals. Halberd has managed to make many such findings throughout this year and it may be a good idea for investors to keep an eye on it.
